Qingdao, China

Rufang Xu

This inventor holds 3 USPTO granted patents. Top assignee: Ocean University of China. Active years: 2020-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rufang Xu. Retrieved from https://idiyas.com/inventor/rufang-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1


Location History:

  • Qingdao, CN (2020)
  • Shandong, CN (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Inventor Rufang Xu

Introduction

Rufang Xu is a notable inventor based in Qingdao, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral drugs. With a total of three patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Rufang Xu's latest patents include a lactam compound, its preparation method, and its use as a pharmaceutical composition. This compound is notable for its potential applications as an antiviral drug. Another significant patent involves alkaloids and their preparation and application as anti-HSV-1 agents. These alkaloids, isolated from marine fungi, demonstrate promising antiviral properties, particularly for treating HSV-1 infections.

Career Highlights

Rufang Xu is affiliated with the Ocean University of China, where he conducts research and development in the field of pharmaceuticals. His innovative work has positioned him as a key figure in the advancement of antiviral therapies.

Collaborations

Rufang Xu collaborates with esteemed colleagues, including Changlun Shao and Changyun Wang. Their combined expertise enhances the research efforts at the Ocean University of China.

Conclusion

Rufang Xu's contributions to the field of pharmaceuticals, particularly through his innovative patents, highlight his role as a leading inventor in antiviral drug development. His work continues to impact the scientific community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…